Qian Kevin, Wang Lian, Cywin Charles L, Farmer Bennett T, Hickey Eugene, Homon Carol, Jakes Scott, Kashem Mohammed A, Lee George, Leonard Scott, Li Jun, Magboo Ronald, Mao Wang, Pack Edward, Peng Charlene, Prokopowicz Anthony, Welzel Morgan, Wolak John, Morwick Tina
Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, Connecticut 06801-0368, USA.
J Med Chem. 2009 Apr 9;52(7):1814-27. doi: 10.1021/jm801242y.
A series of inhibitors of Pim-2 kinase identified by high-throughput screening is described. Details of the hit validation and lead generation process and structure-activity relationship (SAR) studies are presented. Disclosure of an unconventional binding mode for 1, as revealed by X-ray crystallography using the highly homologous Pim-1 protein, is also presented, and observed binding features are shown to correlate with the Pim-2 SAR. While highly selective within the kinase family, the series shows similar potency for both Pim-1 and Pim-2, which was expected on the basis of homology, but unusual in light of reports in the literature documenting a bias for Pim-1. A rationale for these observations based on Pim-1 and Pim-2 K(M(ATP)) values is suggested. Some interesting cross reactivity with casein kinase-2 was also identified, and structural features which may contribute to the association are discussed.
本文描述了通过高通量筛选鉴定出的一系列Pim-2激酶抑制剂。文中介绍了活性验证、先导化合物生成过程以及构效关系(SAR)研究的详细情况。还展示了利用高度同源的Pim-1蛋白通过X射线晶体学揭示的化合物1的非常规结合模式,并且观察到的结合特征与Pim-2的SAR相关。该系列在激酶家族中具有高度选择性,对Pim-1和Pim-2表现出相似的活性,基于同源性这是预期的,但鉴于文献报道Pim-1存在偏向性,这一结果并不寻常。基于Pim-1和Pim-2的K(M(ATP))值对这些观察结果给出了一种解释。还发现了与酪蛋白激酶-2的一些有趣的交叉反应性,并讨论了可能导致这种关联的结构特征。